HemoClear Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Latest Deal Amount
  • $4.59M

  • Investors
  • 2

HemoClear General Information

Description

Developer of an autologous blood processing platform designed to improve patient blood management and expand access to autologous transfusion. The company's platform offers gravity-driven blood processing, recovery and retransfusion of a patient's own red blood cells and platelets without electricity or capital equipment, enabling healthcare providers across surgical, trauma, obstetric, critical care, and military settings to reduce dependence on donor blood and improve blood availability.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Ceintuurbaan 28
  • 8024 AA Zwolle
  • Netherlands
+31 06
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Therapeutic Devices
Vertical(s)
Corporate Office
  • Ceintuurbaan 28
  • 8024 AA Zwolle
  • Netherlands
+31 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HemoClear Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round $4.59M In Progress
3. Debt - General 16-Jun-2020 Completed Generating Revenue/Not Profitable
2. Accelerator/Incubator 13-Jun-2020 $33.2K $33.2K Completed Generating Revenue/Not Profitable
1. Accelerator/Incubator 01-Mar-2016 Completed Generating Revenue/Not Profitable
To view HemoClear’s complete valuation and funding history, request access »

HemoClear Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an autologous blood processing platform designed to improve patient blood management and expand access to a
Surgical Devices
Zwolle, Netherlands
5 As of 2025

Boston, MA
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HemoClear Competitors (4)

One of HemoClear’s 4 competitors is Haemonetics, a Formerly PE-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Haemonetics Formerly PE-Backed Boston, MA
Medtronic Corporation Minneapolis, MN
LivaNova Formerly VC-backed London, United Kingdom
Fresenius Corporation Bad Homburg, Germany
To view HemoClear’s complete competitors history, request access »

HemoClear Patents

HemoClear Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4121138-A2 Blood separation system and blood products Pending 20-Mar-2020
US-20230173147-A1 Blood separation system and blood products Pending 20-Mar-2020
WO-2021187988-A2 Blood separation system and blood products Inactive 20-Mar-2020
WO-2021187988-A3 Blood separation system and blood products Inactive 20-Mar-2020 A61M1/0281

HemoClear Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HemoClear Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIT Health Accelerator/Incubator
medical2market Corporation Minority
To view HemoClear’s complete investors history, request access »

HemoClear FAQs

  • When was HemoClear founded?

    HemoClear was founded in 2015.

  • Where is HemoClear headquartered?

    HemoClear is headquartered in Zwolle, Netherlands.

  • What is the size of HemoClear?

    HemoClear has 5 total employees.

  • What industry is HemoClear in?

    HemoClear’s primary industry is Surgical Devices.

  • Is HemoClear a private or public company?

    HemoClear is a Private company.

  • What is the current valuation of HemoClear?

    The current valuation of HemoClear is .

  • What is HemoClear’s current revenue?

    The current revenue for HemoClear is .

  • How much funding has HemoClear raised over time?

    HemoClear has raised $33.2K.

  • Who are HemoClear’s investors?

    EIT Health and medical2market have invested in HemoClear.

  • Who are HemoClear’s competitors?

    Haemonetics, Medtronic, LivaNova, and Fresenius are competitors of HemoClear.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process